Sam Li is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Project Manager and Analyst at Primera Analytical Solutions Corp. since April 2011. Prior experience includes a tenure as a Scientist at Johnson & Johnson from July 2002 to January 2010 and as Scientist I at Schering-Plough Pharmaceuticals from September 1996 to July 2002, focusing on drug discovery, chemical research, process optimization, and crystallization of pharmaceutical salts. Sam Li holds a PhD in Organic Chemistry from Clemson University and two degrees from Sichuan University, including an M.S. in Medicinal Chemistry and a B.S. in Chemistry.
This person is not in any offices
Primera Analytical Solutions Corporation
Primera Analytical Solutions is a GLP and GMP CRO in great standing with the FDA. Our primary objectives are quality and to become a trusted partner. Services include: - Large and small molecule CMC, bioanalytical, release testing. Method development/validation, method transfer (Assay, Impurities, Dissolution, PK/PD, ADA, cell-based/non cell-based NAb) - Cell & Gene Therapy (FACS, qPCR, ddPCR, cell-based assays - Cell potency assays - Impurity studies (LC/MS/MS, GC/MS, ICP/MS) - Extractable and leachable studies - Stability studies - Dissolution - Abuse-deterrent studies - Solid state characterization - Product and raw material release testing - Metabolite characterization, bioavailability and bioequivalence studies - Bioassay method development and validation - Impurities by ELISA - Peptide mapping - HRMS